TDP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.895800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.378000E-01
Normal-vs-Stage2
5.200400E-01
Normal-vs-Stage3
2.364400E-01
Normal-vs-Stage4
3.969600E-01
Stage1-vs-Stage2
5.625400E-01
Stage1-vs-Stage3
9.066500E-02
Stage1-vs-Stage4
9.041600E-01
Stage2-vs-Stage3
3.861700E-02
Stage2-vs-Stage4
7.381600E-01
Stage3-vs-Stage4
1.725210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.998000E-01
Normal-vs-AfricanAmerican
4.312200E-01
Normal-vs-Asian
1.443960E-01
Caucasian-vs-AfricanAmerican
6.138600E-01
Caucasian-vs-Asian
4.813600E-01
AfricanAmerican-vs-Asian
9.802400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.446800E-01
Normal-vs-Female
2.308600E-01
Male-vs-Female
7.862300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.032800E-01
Normal-vs-Age(41-60Yrs)
6.078400E-01
Normal-vs-Age(61-80Yrs)
7.940300E-02
Normal-vs-Age(81-100Yrs)
5.143800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.344600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.979200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.832800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.290390E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.261200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.375200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.811180E-01
Normal-vs-Daily Drinker
4.819400E-01
Normal-vs-Weekly Drinker
3.456000E-01
Normal-vs-Occasional Drinker
4.675600E-01
Normal-vs-Social Drinker
5.578200E-01
Non Drinker-vs-Daily Drinker
8.514600E-01
Non Drinker-vs-Weekly Drinker
7.752800E-01
Non Drinker-vs-Occasional Drinker
9.200200E-01
Non Drinker-vs-Social Drinker
3.868400E-01
Daily Drinker-vs-Weekly Drinker
8.778000E-01
Daily Drinker-vs-Occasional Drinker
9.045600E-01
Daily Drinker-vs-Social Drinker
5.091400E-01
Weekly Drinker-vs-Occasional Drinker
8.240200E-01
Weekly Drinker-vs-Social Drinker
7.634800E-01
Occasional Drinker-vs-Social Drinker
3.396400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.291200E-01
Normal-vs-Grade 2
8.782600E-01
Normal-vs-Grade 3
9.176400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.436800E-01
Grade 1-vs-Grade 3
1.046640E-01
Grade 1-vs-Grade 4
8.291200E-01
Grade 2-vs-Grade 3
2.466000E-01
Grade 2-vs-Grade 4
8.782600E-01
Grade 3-vs-Grade 4
9.176400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.837800E-01
Normal-vs-NonDiabetic
4.656000E-01
Diabetic-vs-NonDiabetic
8.066200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.435200E-01
Normal-vs-NoPancreatitis
4.763600E-01
Pancreatitis-vs-NoPancreatitis
7.171000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.017970E-01
Normal-vs-N1
5.155200E-01
N0-vs-N1
3.522200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.306400E-01
Normal-vs-TP53-NonMutant
1.677850E-01
TP53-Mutant-vs-TP53-NonMutant
4.665000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
